Polymeric biomaterials for in vitro cancer tissue engineering and drug testing applications

Tissue Engineering - Part B: Reviews

Volumn 22, Issue 6, 2016, Pages 470-484

  Pradhan, Shantanu ^a   Hassani, Iman ^a   Clary, Jacob M ^a   Lipke, Elizabeth A ^a  

^a AUBURN UNIVERSITY   (United States)

Author keywords

3D cell culture; biomechanics; biomimetic materials; degradable hydrogels; extracellular matrix; tumor microenvironment

Indexed keywords

BIOMATERIALS; BIOMECHANICS; BIOMIMETIC MATERIALS; BIOMIMETICS; CELL CULTURE; CELLS; CYTOLOGY; DISEASES; ENZYME ACTIVITY; ENZYME INHIBITION; FUNCTIONAL POLYMERS; HYDROGELS; PHYSIOLOGICAL MODELS; POLYMERS; TISSUE; TISSUE ENGINEERING; TISSUE REGENERATION;

3-D CELL CULTURE; BIOLOGICAL PHENOMENA; CELL MATRIX INTERACTIONS; DEGRADABLE HYDROGEL; EXTRACELLULAR MATRICES; POLYMERIC BIOMATERIALS; THREEDIMENSIONAL (3-D); TUMOR MICROENVIRONMENT;

THREE DIMENSIONAL COMPUTER GRAPHICS;

ALGINIC ACID; ANTINEOPLASTIC AGENT; BIOMATERIAL; HYALURONIC ACID; SILK FIBROIN; POLYMER;

CANCER RESEARCH; CANCER TISSUE; DRUG DESIGN; DRUG SCREENING; HUMAN; IN VITRO STUDY; NONHUMAN; PLANT; POLYMERIZATION; PRIORITY JOURNAL; REVIEW; TISSUE ENGINEERING; BIOMIMETICS; CELL CULTURE TECHNIQUE; NEOPLASM;

BIOCOMPATIBLE MATERIALS; BIOMIMETICS; CELL CULTURE TECHNIQUES; HUMANS; NEOPLASMS; POLYMERS; TISSUE ENGINEERING;

EID: 85011643519     PISSN: 19373368     EISSN: 19373376     Source Type: Journal    
DOI: 10.1089/ten.teb.2015.0567     Document Type: Review

References (165)

1. Risk Factors for Cancer. National Cancer Institute; 2015.
2. Workman, P., and Kaye, S.B. Translating basic cancer research into new cancer therapeutics. Trends Mol Med 8, S1, 2002.
3. de Bono, J.S., and Ashworth, A. Translating cancer research into targeted therapeutics. Nature 467, 543, 2010.
4. Albini, A., and Sporn, M.B. The tumour microenvironment as a target for chemoprevention. Nat Rev Cancer 7, 139, 2007.
5. Nyga, A., Cheema, U., and Loizidou, M. 3D tumour models: novel in vitro approaches to cancer studies. J Cell Commun Signal 5, 239, 2011.
6. Cox, M.C., Reese, L.M., Bickford, L.R., and Verbridge, S.S. Toward the broad adoption of 3D tumor models in the cancer drug pipeline. ACS Biomater Sci Eng 1, 877, 2015.
7. Burdett, E., Kasper, F.K., Mikos, A.G., and Ludwig, J.A. Engineering tumors: a tissue engineering perspective in cancer biology. Tissue Eng Part B 16, 351, 2010.
8. Chakrabarti, A., Verbridge, S., Stroock, A., Fischbach, C., and Varner, J. Multiscale models of breast cancer progression. Ann Biomed Eng 40, 2488, 2012.
9. Xu, F., and Burg, K.J. Three-dimensional polymeric systems for cancer cell studies. Cytotechnology 54, 135, 2007.
10. Alemany-Ribes, M., and Semino, C.E. Bioengineering 3D environments for cancer models. Adv Drug Deliv Rev 79, 40, 2014.
11. Bradbury, P., Fabry, B., and O Neill, G.M. Occupy tissue: the movement in cancer metastasis. Cell Adh Migr 6, 424, 2012.
12. Rijal, G., and Li, W. 3D scaffolds in breast cancer research. Biomaterials 81, 135, 2016.
13. Griffith, L.G., and Swartz, M.A. Capturing complex 3D tissue physiology in vitro. Nat Rev Mol Cell Biol 7, 211, 2006.
14. Weigelt, B., Ghajar, C.M., and Bissell, M.J. The need for complex 3D culture models to unravel novel pathways and identify accurate biomarkers in breast cancer. Adv Drug Deliv Rev 69, 42, 2014.
15. Ajani, J.A., Song, S., Hochster, H.S., and Steinberg, I.B. Cancer stem cells: the promise and the potential. Semin Oncol 42 Suppl 1, S3, 2015.
16. Jordan, C.T., Guzman, M.L., and Noble, M. Cancer stem cells. N Engl J Med 355, 1253, 2006.
17. Gill, B.J., and West, J.L. Modeling the tumor extracellular matrix: tissue engineering tools repurposed towards new frontiers in cancer biology. J Biomech 47, 1969, 2014.
18. Seo, B.R., DelNero, P., and Fischbach, C. In vitro models of tumor vessels and matrix: engineering approaches to investigate transport limitations and drug delivery in cancer. Adv Drug Deliv Rev 69, 205, 2014.
19. Chwalek, K., Bray, L.J., and Werner, C. Tissueengineered 3D tumor angiogenesis models: potential technologies for anti-cancer drug discovery. Adv Drug Deliv Rev 79, 30, 2014.
20. Yamada, K.M., and Cukierman, E. Modeling tissue morphogenesis and cancer in 3D. Cell 130, 601, 2007.
21. Nguyen, K.T., and West, J.L. Photopolymerizable hydrogels for tissue engineering applications. Biomaterials 23, 4307, 2002.
22. Hoffman, A.S. Hydrogels for biomedical applications. Adv Drug Deliv Rev 64, 18, 2012.
23. Hutmacher, D.W. Biomaterials offer cancer research the third dimension. Nat Mater 9, 90, 2010.
24. Szot, C.S., Buchanan, C.F., Freeman, J.W., and Rylander, M.N. 3D in vitro bioengineered tumors based on collagen I hydrogels. Biomaterials 32, 7905, 2011.
25. Chen, L., Xiao, Z., Meng, Y., Zhao, Y., Han, J., Su, G., Chen, B., and Dai, J. The enhancement of cancer stem cell properties of MCF-7 cells in 3D collagen scaffolds for modeling of cancer and anti-cancer drugs. Biomaterials 33, 1437, 2012.
26. Koutsilieris, M., Sourla, A., Pelletier, G., and Doillon, C.J. Three-dimensional type I collagen gel system for the study of osteoblastic metastases produced by metastatic prostate cancer. J Bone Miner Res 9, 1823, 1994.
27. Fang, J.Y., Tan, S.J., Yang, Z., Tayag, C., and Han, B. Tumor bioengineering using a transglutaminase crosslinked hydrogel. PLoS One 9, e105616, 2014.
28. Bersini, S., Jeon, J.S., Dubini, G., Arrigoni, C., Chung, S., Charest, J.L., Moretti, M., and Kamm, R.D. A microfluidic 3D in vitro model for specificity of breast cancer metastasis to bone. Biomaterials 35, 2454, 2014.
29. Provenzano, P.P., Inman, D.R., Eliceiri, K.W., Knittel, J.G., Yan, L., Rueden, C.T., White, J.G., and Keely, P.J. Collagen density promotes mammary tumor initiation and progression. BMC Med 6, 11, 2008.
30. Cassereau, L., Miroshnikova, Y.A., Ou, G., Lakins, J., and Weaver, V.M. A 3D tension bioreactor platform to study the interplay between ECM stiffness and tumor phenotype. J Biotechnol 193, 66, 2015.
31. Guzman, A., Ziperstein, M.J., and Kaufman, L.J. The effect of fibrillar matrix architecture on tumor cell invasion of physically challenging environments. Biomaterials 35, 6954, 2014.
32. Bordeleau, F., Tang, L.N., and Reinhart-King, C.A. Topographical guidance of 3D tumor cell migration at an interface of collagen densities. Phys Biol 10, 065004, 2013.
33. Sapudom, J., Rubner, S., Martin, S., Kurth, T., Riedel, S., Mierke, C.T., and Pompe, T. The phenotype of cancer cell invasion controlled by fibril diameter and pore size of 3D collagen networks. Biomaterials 52, 367, 2015.
34. Carey, S.P., Rahman, A., Kraning-Rush, C.M., Romero, B., Somasegar, S., Torre, O.M., Williams, R.M., and Reinhart-King, C.A. Comparative mechanisms of cancer cell migration through 3D matrix and physiological microtracks. Am J Physiol Cell Physiol 308, C436, 2015.
35. Riching, K.M., Cox, B.L., Salick, M.R., Pehlke, C., Riching, A.S., Ponik, S.M., Bass, B.R., Crone, W.C., Jiang, Y., Weaver, A.M., Eliceiri, K.W., and Keely, P.J. 3D collagen alignment limits protrusions to enhance breast cancer cell persistence. Biophys J 107, 2546, 2014.
36. Lautscham, L.A., Kammerer, C., Lange, J.R., Kolb, T., Mark, C., Schilling, A., Strissel, P.L., Strick, R., Gluth, C., Rowat, A.C., Metzner, C., and Fabry, B. Migration in confined 3D environments is determined by a combination of adhesiveness, nuclear volume, contractility, and cell Stiffness. Biophys J 109, 900, 2015.
37. Martinez-Ramos, C., and Lebourg, M. Three-dimensional constructs using hyaluronan cell carrier as a tool for the study of cancer stem cells. J Biomed Mater Res Part B 103, 1249, 2015.
38. Thao, T.T.V., Lim, C., and Lim, M. Characterization of leukemic cell behaviors in a soft marrow mimetic alginate hydrogel. J Biomed Mater Res B 100b, 1980, 2012.
39. Kleinman, H.K., and Martin, G.R. Matrigel: basement membrane matrix with biological activity. Semin Cancer Biol 15, 378, 2005.
40. Benton, G., Arnaoutova, I., George, J., Kleinman, H.K., and Koblinski, J. Matrigel: from discovery and ECM mimicry to assays and models for cancer research. Adv Drug Deliv Rev 79, 3, 2014.
41. Pradhan, S., Chaudhury, C.S., and Lipke, E.A. Dualphase, surface tension-based fabrication method for generation of tumor millibeads. Langmuir 30, 3817, 2014.
42. Wang, C., Tong, X., and Yang, F. Bioengineered 3D brain tumor model to elucidate the effects of matrix stiffness on glioblastoma cell behavior using PEG-based hydrogels. Mol Pharm 11, 2115, 2014.
43. Fong, E.L., Lamhamedi-Cherradi, S.E., Burdett, E., Ramamoorthy, V., Lazar, A.J., Kasper, F.K., Farach-Carson, M.C., Vishwamitra, D., Demicco, E.G., Menegaz, B.A., Amin, H.M., Mikos, A.G., and Ludwig, J.A. Modeling Ewing sarcoma tumors in vitro with 3D scaffolds. Proc Natl Acad Sci U S A 110, 6500, 2013.
44. Sieh, S., Taubenberger, A.V., Rizzi, S.C., Sadowski, M., Lehman, M.L., Rockstroh, A., An, J., Clements, J.A., Nelson, C.C., and Hutmacher, D.W. Phenotypic characterization of prostate cancer LNCaP cells cultured within a bioengineered microenvironment. PLoS One 7, e40217, 2012.
45. Yeung, T.M., Gandhi, S.C., Wilding, J.L., Muschel, R., and Bodmer, W.F. Cancer stem cells from colorectal cancerderived cell lines. ProcNatlAcad SciUSA107, 3722, 2010.
46. Sasser, A.K., Mundy, B.L., Smith, K.M., Studebaker, A.W., Axel, A.E., Haidet, A.M., Fernandez, S.A., and Hall, B.M. Human bonemarrowstromal cells enhance breast cancer cell growth rates in a cell line-dependentmanner when evaluated in 3D tumor environments. Cancer Lett 254, 255, 2007.
47. Topley, P., Jenkins, D.C., Jessup, E.A., and Stables, J.N. Effect of reconstituted basement membrane components on the growth of a panel of human tumour cell lines in nude mice. Br J Cancer 67, 953, 1993.
48. Olsen, C.J., Moreira, J., Lukanidin, E.M., and Ambartsumian, N.S. Human mammary fibroblasts stimulate invasion of breast cancer cells in a three-dimensional culture and increase stroma development in mouse xenografts. BMC Cancer 10, 444, 2010.
49. Pinto, M.P., Dye, W.W., Jacobsen, B.M., and Horwitz, K.B. Malignant stroma increases luminal breast cancer cell proliferation and angiogenesis through platelet-derived growth factor signaling. BMC Cancer 14, 735, 2014.
50. Augustine, T.N., Dix-Peek, T., Duarte, R., and Candy, G.P. Establishment of a heterotypic 3D culture system to evaluate the interaction of TREG lymphocytes and NK cells with breast cancer. J Immunol Methods 426, 1, 2015.
51. Yu, X., and Machesky, L.M. Cells assemble invadopodialike structures and invade into matrigel in a matrix metalloprotease dependent manner in the circular invasion assay. PLoS One 7, e30605, 2012.
52. Zhu, J., Liang, L., Jiao, Y., Liu, L., and Alliance, U.S.-C.P. S.-O. Enhanced invasion of metastatic cancer cells via extracellular matrix interface. PLoS One 10, e0118058, 2015.
53. Kramer, R.H., Bensch, K.G., and Wong, J. Invasion of reconstituted basement membrane matrix by metastatic human tumor cells. Cancer Res 46, 1980, 1986.
54. Bae, S.N., Arand, G., Azzam, H., Pavasant, P., Torri, J., Frandsen, T.L., and Thompson, E.W. Molecular and cellular analysis of basement membrane invasion by human breast cancer cells in Matrigel-based in vitro assays. Breast Cancer Res Treat 24, 241, 1993.
55. Workman, V.L., Tezera, L.B., Elkington, P.T., and Jayasinghe, S.N. Controlled generation of microspheres incorporating extracellular matrix fibrils for three-dimensional cell culture. Adv Funct Mater 24, 2648, 2014.
56. Kingsley, D.M., Dias, A.D., Chrisey, D.B., and Corr, D.T. Single-step laser-based fabrication and patterning of cellencapsulated alginate microbeads. Biofabrication 5, 045006, 2013.
57. Draget, K.I., Skjak-Braek, G., and Smidsrod, O. Alginate based new materials. Int J Biol Macromol 21, 47, 1997.
58. Godugu, C., Patel, A.R., Desai, U., Andey, T., Sams, A., and Singh, M. AlgiMatrix (TM) based 3D cell culture system as an in-vitro tumor model for anticancer studies. PLoS One 8, e53708, 2013.
59. Raof, N.A., Raja, W.K., Castracane, J., and Xie, Y. Bioengineering embryonic stem cell microenvironments for exploring inhibitory effects on metastatic breast cancer cells. Biomaterials 32, 4130, 2011.
60. Xu, X.X., Liu, C., Liu, Y., Yang, L., Li, N., Guo, X., Sun, G.W., and Ma, X.J. Enrichment of cancer stemcell-like cells by culture in alginate gel beads. J Biotechnol 177, 1, 2014.
61. Liu, C., Liu, Y., Xu, X.X., Wu, H., Xie, H.G., Chen, L., Lu, T., Yang, L., Guo, X., Sun, G.W., Wang, W., Ma, X.J., and He, X. Potential effect of matrix stiffness on the enrichment of tumor initiating cells under three-dimensional culture conditions. Exp Cell Res 330, 123, 2015.
62. Liu, C., Liu, Y., Xie, H.G., Zhao, S., Xu, X.X., Fan, L.X., Guo, X., Lu, T., Sun, G.W., and Ma, X.J. Role of threedimensional matrix stiffness in regulating the chemoresistance of hepatocellular carcinoma cells. Biotechnol Appl Biochem 62, 556, 2015.
63. DelNero, P., Lane, M., Verbridge, S.S., Kwee, B., Kermani, P., Hempstead, B., Stroock, A., and Fischbach, C. 3D culture broadly regulates tumor cell hypoxia response and angiogenesis via pro-inflammatory pathways. Biomaterials 55, 110, 2015.
64. Smith, B.H., Gazda, L.S., Conn, B.L., Jain, K., Asina, S., Levine, D.M., Parker, T.S., Laramore, M.A., Martis, P.C., Vinerean, H.V., David, E.M., Qiu, S., Cordon-Cardo, C., Hall, R.D., Gordon, B.R., Diehl, C.H., Stenzel, K.H., and Rubin, A.L. Three-dimensional culture of mouse renal carcinoma cells in agarose macrobeads selects for a subpopulation of cells with cancer stem cell or cancer progenitor properties. Cancer Res 71, 716, 2011.
65. Smith, B.H., Gazda, L.S., Conn, B.L., Jain, K., Asina, S., Levine, D.M., Parker, T.S., Laramore, M.A., Martis, P.C., Vinerean, H.V., David, E.M., Qiu, S., North, A.J., Couto, C.G., Post, G.S., Waters, D.J., Cordon-Cardo, C., Hall, R.D., Gordon, B.R., Diehl, C.H., Stenzel, K.H., and Rubin, A.L. Hydrophilic agarose macrobead cultures select for outgrowth of carcinoma cell populations that can restrict tumor growth. Cancer Res 71, 725, 2011.
66. Vantangoli, M.M., Madnick, S.J., Huse, S.M., Weston, P., and Boekelheide, K. MCF-7 human breast cancer cells form differentiated microtissues in scaffold-free hydrogels. PLoS One 10, e0135426, 2015.
67. Laurent, T.C., and Fraser, J.R. Hyaluronan. FASEB J 6, 2397, 1992.
68. Tian, X., Azpurua, J., Hine, C., Vaidya, A., Myakishev-Rempel, M., Ablaeva, J., Mao, Z., Nevo, E., Gorbunova, V., and Seluanov, A. High-molecular-mass hyaluronan mediates the cancer resistance of the naked mole rat. Nature 499, 346, 2013.
69. Adamia, S., Maxwell, C.A., and Pilarski, L.M. Hyaluronan and hyaluronan synthases: potential therapeutic targets in cancer. Curr Drug Targets Cardiovasc Haematol Disord 5, 3, 2005.
70. Wu, M., Cao, M., He, Y., Liu, Y., Yang, C., Du, Y., Wang, W., and Gao, F. A novel role of low molecular weight hyaluronan in breast cancermetastasis.FASEBJ 29, 1290, 2015.
71. Rayahin, J.E., Buhrman, J.S., Zhang, Y., Koh, T.J., and Gemeinhart, R.A. High and low, molecular weight hyaluronic acid differentially influence macrophage activation. ACS Biomater Sci Eng 1, 481, 2015.
72. Gurski, L.A., Xu, X., Labrada, L.N., Nguyen, N.T., Xiao, L., van Golen, K.L., Jia, X., and Farach-Carson, M.C. Hyaluronan (HA) interacting proteins RHAMM and hyaluronidase impact prostate cancer cell behavior and invadopodia formation in 3D HA-based hydrogels. PLoS One 7, e50075, 2012.
73. Xu, X., Gurski, L.A., Zhang, C., Harrington, D.A., Farach-Carson, M.C., and Jia, X. Recreating the tumor microenvironment in a bilayer, hyaluronic acid hydrogel construct for the growth of prostate cancer spheroids. Biomaterials 33, 9049, 2012.
74. David, L., Dulong, V., Le Cerf, D., Chauzy, C., Norris, V., Delpech, B., Lamacz, M., and Vannier, J.P. Reticulated hyaluronan hydrogels: a model for examining cancer cell invasion in 3D. Matrix Biol 23, 183, 2004.
75. Talukdar, S., Mandal, M., Hutmacher, D.W., Russell, P.J., Soekmadji, C., and Kundu, S.C. Engineered silk fibroin protein 3D matrices for in vitro tumor model. Biomaterials 32, 2149, 2011.
76. Tan, P.H., Aung, K.Z., Toh, S.L., Goh, J.C., and Nathan, S.S. Three-dimensional porous silk tumor constructs in the approximation of in vivo osteosarcoma physiology. Biomaterials 32, 6131, 2011.
77. Kundu, B., Saha, P., Datta, K., and Kundu, S.C. A silk fibroin based hepatocarcinoma model and the assessment of the drug response in hyaluronan-binding protein 1 overexpressed HepG2 cells. Biomaterials 34, 9462, 2013.
78. Seib, F.P., Berry, J.E., Shiozawa, Y., Taichman, R.S., and Kaplan, D.L. Tissue engineering a surrogate niche for metastatic cancer cells. Biomaterials 51, 313, 2015.
79. Kwon, H., Kim, H.J., Rice, W.L., Subramanian, B., Park, S.H., Georgakoudi, I., and Kaplan, D.L. Development of an in vitro model to study the impact of BMP-2 on metastasis to bone. J Tissue Eng Regen Med 4, 590, 2010.
80. Bulysheva, A.A., Bowlin, G.L., Petrova, S.P., and Yeudall, W.A. Enhanced chemoresistance of squamous carcinoma cells grown in 3D cryogenic electrospun scaffolds. Biomed Mater 8, 055009, 2013.
81. Maghdouri-White, Y., Bowlin, G.L., Lemmon, C.A., and Dreau, D. Bioengineered silk scaffolds in 3D tissue modeling with focus on mammary tissues. Mater Sci Eng C Mater Biol Appl 59, 1168, 2016.
82. Kapoor, S., and Kundu, S.C. Silk protein-based hydrogels: promising advanced materials for biomedical applications. Acta Biomater 31, 17, 2016.
83. Dhiman, H.K., Ray, A.R., and Panda, A.K. Characterization and evaluation of chitosan matrix for in vitro growth of MCF-7 breast cancer cell lines. Biomaterials 25, 5147, 2004.
84. Liu, J., Tan, Y., Zhang, H., Zhang, Y., Xu, P., Chen, J., Poh, Y.C., Tang, K., Wang, N., and Huang, B. Soft fibrin gels promote selection and growth of tumorigenic cells. Nat Mater 11, 734, 2012.
85. Tan, Y., Tajik, A., Chen, J., Jia, Q., Chowdhury, F., Wang, L., Chen, J., Zhang, S., Hong, Y., Yi, H., Wu, D.C., Zhang, Y., Wei, F., Poh, Y.C., Seong, J., Singh, R., Lin, L.J., Doganay, S., Li, Y., Jia, H., Ha, T., Wang, Y., Huang, B., and Wang, N. Matrix softness regulates plasticity of tumour-repopulating cells via H3K9 demethylation and Sox2 expression. Nat Commun 5, 4619, 2014.
86. Goodly, L.J., Singh, R.K., Wang, M.H., and Siegal, G.P. In vivo modulation of human tumor cell growth by normal human extracellular matrix. Tumour Biol 15, 326, 1994.
87. Siegal, G.P., Wang, M.H., Rinehart, C.A., Jr., Kennedy, J.W., Goodly, L.J., Miller, Y., Kaufman, D.G., and Singh, R.K. Development of a novel human extracellular matrix for quantitation of the invasiveness of human cells. Cancer Lett 69, 123, 1993.
88. Zustiak, S.P., and Leach, J.B. Hydrolytically degradable poly(ethylene glycol) hydrogel scaffolds with tunable degradation and mechanical properties. Biomacromolecules 11, 1348, 2010.
89. Kloxin, A.M., Tibbitt, M.W., and Anseth, K.S. Synthesis of photodegradable hydrogels as dynamically tunable cell culture platforms. Nat Protoc 5, 1867, 2010.
90. Kloxin, A.M., Kasko, A.M., Salinas, C.N., and Anseth, K.S. Photodegradable hydrogels for dynamic tuning of physical and chemical properties. Science 324, 59, 2009.
91. Zhu, J. Bioactive modification of poly(ethylene glycol) hydrogels for tissue engineering. Biomaterials 31, 4639, 2010.
92. Leight, J.L., Tokuda, E.Y., Jones, C.E., Lin, A.J., and Anseth, K.S. Multifunctional bioscaffolds for 3D culture of melanoma cells reveal increased MMP activity and migration with BRAF kinase inhibition. Proc Natl Acad Sci U S A 112, 5366, 2015.
93. Raeber, G.P., Lutolf, M.P., and Hubbell, J.A. Molecularly engineered PEG hydrogels: a novel model system for proteolytically mediated cell migration. Biophys J 89, 1374, 2005.
94. Gill, B.J., Gibbons, D.L., Roudsari, L.C., Saik, J.E., Rizvi, Z.H., Roybal, J.D., Kurie, J.M., and West, J.L. A synthetic matrix with independently tunable biochemistry and mechanical properties to study epithelial morphogenesis and EMT in a lung adenocarcinoma model. Cancer Res 72, 6013, 2012.
95. Singh, S.P., Schwartz, M.P., Lee, J.Y., Fairbanks, B.D., and Anseth, K.S. A peptide functionalized poly(ethylene glycol) (PEG) hydrogel for investigating the influence of biochemical and biophysical matrix properties on tumor cell migration. Biomater Sci 2, 1024, 2014.
96. Yang, X., Sarvestani, S.K., Moeinzadeh, S., He, X., and Jabbari, E. Three-dimensional-engineered matrix to study cancer stem cells and tumorsphere formation: effect of matrix modulus. Tissue Eng Part A 19, 669, 2013.
97. Jabbari, E., Sarvestani, S.K., Daneshian, L., and Moeinzadeh, S. Optimum 3D matrix stiffness for maintenance of cancer stem cells is dependent on tissue origin of cancer cells. PLoS One 10, e0132377, 2015.
98. Yang, X., Sarvestani, S.K., Moeinzadeh, S., He, X., and Jabbari, E. Effect of CD44 binding peptide conjugated to an engineered inert matrix on maintenance of breast cancer stem cells and tumorsphere formation. PLoS One 8, e59147, 2013.
99. Weiss, M.S., Bernabé, B.P., Shikanov, A., Bluver, D.A., Mui, M.D., Shin, S., Broadbelt, L.J., and Shea, L.D. The impact of adhesion peptides within hydrogels on the phenotype and signaling of normal and cancerous mammary epithelial cells. Biomaterials 33, 3548, 2012.
100. Sahoo, S.K., Panda, A.K., and Labhasetwar, V. Characterization of porous PLGA/PLA microparticles as a scaffold for three dimensional growth of breast cancer cells. Biomacromolecules 6, 1132, 2005.
101. Kang, S.W., andBae, Y.H.Cryopreservable and tumorigenic three-dimensional tumor culture in porous poly(lactic-coglycolic acid) microsphere. Biomaterials 30, 4227, 2009.
102. Zhu, X.H., Lee, L.Y., Jackson, J.S.H., Tong, Y.W., and Wang, C.-H. Characterization of porous poly(D, L-lacticco-glycolic acid) sponges fabricated by supercritical CO2 gas-foaming method as a scaffold for three-dimensional growth of Hep3B cells. Biotechnol Bioeng 100, 998, 2008.
103. Ho, W.J., Pham, E.a., Kim, J.W., Ng, C.W., Kim, J.H., Kamei, D.T., and Wu, B.M. Incorporation of multicellular spheroids into 3-D polymeric scaffolds provides an improved tumor model for screening anticancer drugs. Cancer Sci 101, 2637, 2010.
104. Zhang, T., Zhang, Q., Chen, J., Fang, K., Dou, J., and Gu, N. The controllable preparation of porous PLGA microspheres by the oil/water emulsion method and its application in 3D culture of ovarian cancer cells. Colloids Surf A 452, 115, 2014.
105. Girard, Y.K., Wang, C., Ravi, S., Howell, M.C., Mallela, J., Alibrahim, M., Green, R., Hellermann, G., Mohapatra, S.S., and Mohapatra, S. A 3D fibrous scaffold inducing tumoroids: a platform for anticancer drug development. PLoS One 8, e75345, 2013.
106. Fischbach, C., Kong, H.J., Hsiong, S.X., Evangelista, M.B., Yuen, W., and Mooney, D.J. Cancer cell angiogenic capability is regulated by 3D culture and integrin engagement. Proc Natl Acad Sci U S A 106, 399, 2009.
107. Kievit, F.M., Florczyk, S.J., Leung, M.C., Veiseh, O., Park, J.O., Disis, M.L., and Zhang, M. Chitosan-Alginate 3D scaffolds as a mimic of the glioma tumor microenvironment. Biomaterials 31, 5903, 2010.
108. Kievit, F.M., Florczyk, S.J., Leung, M.C., Wang, K., Wu, J.D., Silber, J.R., Ellenbogen, R.G., Lee, J.S., and Zhang, M. Proliferation and enrichment of CD133(+) glioblastoma cancer stem cells on 3D chitosan-Alginate scaffolds. Biomaterials 35, 9137, 2014.
109. Chaudhuri, O., Koshy, S.T., Branco da Cunha, C., Shin, J.W., Verbeke, C.S., Allison, K.H., and Mooney, D.J. Extracellular matrix stiffness and composition jointly regulate the induction of malignant phenotypes in mammary epithelium. Nat Mater 13, 970, 2014.
110. Liang, Y., Jeong, J., DeVolder, R.J., Cha, C., Wang, F., Tong, Y.W., and Kong, H. A cell-instructive hydrogel to regulate malignancy of 3D tumor spheroids with matrix rigidity. Biomaterials 32, 9308, 2011.
111. Beck, J.N., Singh, A., Rothenberg, A.R., Elisseeff, J.H., and Ewald, A.J. The independent roles of mechanical, structural and adhesion characteristics of 3D hydrogels on the regulation of cancer invasion and dissemination. Biomaterials 34, 9486, 2013.
112. Long, T.J., Sprenger, C.C., Plymate, S.R., and Ratner, B.D. Prostate cancer xenografts engineered from 3D precision-porous poly(2-hydroxyethyl methacrylate) hydrogels as models for tumorigenesis and dormancy escape. Biomaterials 35, 8164, 2014.
113. Almany, L., and Seliktar, D. Biosynthetic hydrogel scaffolds made from fibrinogen and polyethylene glycol for 3D cell cultures. Biomaterials 26, 2467, 2005.
114. Plesner, B., Fee, C.J., Westh, P., and Nielsen, A.D. Effects of PEG size on structure, function and stability of PEGylated BSA. Eur J Pharm Biopharm 79, 399, 2011.
115. Lee, B.H., Tin, S.P., Chaw, S.Y., Cao, Y., Xia, Y., Steele, T.W., Seliktar, D., Bianco-Peled, H., and Venkatraman, S.S. Influence of soluble PEG-OH incorporation in a 3D cell-laden PEG-fibrinogen (PF) hydrogel on smooth muscle cell morphology and growth. J Biomater Sci Polym Ed 25, 394, 2014.
116. Shapira-Schweitzer, K., and Seliktar, D. Matrix stiffness affects spontaneous contraction of cardiomyocytes cultured within a PEGylated fibrinogen biomaterial. Acta Biomater 3, 33, 2007.
117. Bearzi, C., Gargioli, C., Baci, D., Fortunato, O., Shapira-Schweitzer, K., Kossover, O., Latronico, M.V., Seliktar, D., Condorelli, G., and Rizzi, R. PlGF-MMP9-engineered iPS cells supported on a PEG-fibrinogen hydrogel scaffold possess an enhanced capacity to repair damaged myocardium. Cell Death Dis 5, e1053, 2014.
118. Fu, Y., Xu, K., Zheng, X., Giacomin, A.J., Mix, A.W., and Kao, W.J. 3D cell entrapment in crosslinked thiolated gelatin-poly(ethylene glycol) diacrylate hydrogels. Biomaterials 33, 48, 2012.
119. Hutson, C.B., Nichol, J.W., Aubin, H., Bae, H., Yamanlar, S., Al-Haque, S., Koshy, S.T., and Khademhosseini, A. Synthesis and characterization of tunable poly(ethylene glycol): gelatin methacrylate composite hydrogels. Tissue Eng Part A 17, 1713, 2011.
120. Pan, T., Fong, E.L., Martinez, M., Harrington, D.A., Lin, S.H., Farach-Carson, M.C., and Satcher, R.L. Threedimensional (3D) culture of bone-derived human 786-O renal cell carcinoma retains relevant clinical characteristics of bone metastases. Cancer Lett 365, 89, 2015.
121. Pedron, S., Becka, E., and Harley, B.A. Regulation of glioma cell phenotype in 3D matrices by hyaluronic acid. Biomaterials 34, 7408, 2013.
122. Huang, H., Ding, Y., Sun, X.S., and Nguyen, T.A. Peptide hydrogelation and cell encapsulation for 3D culture of MCF-7 breast cancer cells. PLoS One 8, e59482, 2013.
123. Florczyk, S.J., Liu, G., Kievit, F.M., Lewis, A.M., Wu, J.D., and Zhang, M. 3D porous chitosan-Alginate scaffolds: a new matrix for studying prostate cancer cell-lymphocyte interactions in vitro. Adv Healthc Mater 1, 590, 2012.
124. Derda, R., Laromaine, A., Mammoto, A., Tang, S.K., Mammoto, T., Ingber, D.E., and Whitesides, G.M. Papersupported 3D cell culture for tissue-based bioassays. Proc Natl Acad Sci U S A 106, 18457, 2009.
125. She, Z., Jin, C., Huang, Z., Zhang, B., Feng, Q., and Xu, Y. Silk fibroin/chitosan scaffold: preparation, characterization, and culture with HepG2 cell. J Mater Sci 19, 3545, 2008.
126. Arya, N., Sardana, V., Saxena, M., Rangarajan, A., and Katti, D.S. Recapitulating tumour microenvironment in chitosan-gelatin three-dimensional scaffolds: an improved in vitro tumour model. J R Soc Interface 9, 3288, 2012.
127. Ulrich, T.A., Jain, A., Tanner, K., MacKay, J.L., and Kumar, S. Probing cellular mechanobiology in threedimensional culture with collagen-Agarose matrices. Biomaterials 31, 1875, 2010.
128. Ricci, C., Mota, C., Moscato, S., D Alessandro, D., Ugel, S., Sartoris, S., Bronte, V., Boggi, U., Campani, D., Funel, N., Moroni, L., and Danti, S. Interfacing polymeric scaffolds with primary pancreatic ductal adenocarcinoma cells to develop 3D cancer models. Biomatter 4, e955386, 2014.
129. Worthington, P., Pochan, D.J., and Langhans, S.A. Peptide hydrogels-versatile matrices for 3D cell culture in cancer medicine. Front Oncol 5, 92, 2015.
130. Nagy-Smith, K., Moore, E., Schneider, J., and Tycko, R. Molecular structure of monomorphic peptide fibrils within a kinetically trapped hydrogel network. Proc Natl Acad Sci U S A 112, 9816, 2015.
131. Yang, Z., and Zhao, X. A 3D model of ovarian cancer cell lines on peptide nanofiber scaffold to explore the cellscaffold interaction and chemotherapeutic resistance of anticancer drugs. Int J Nanomed 6, 303, 2011.
132. Abu-Yousif, A.O., Rizvi, I., Evans, C.L., Celli, J.P., and Hasan, T. PuraMatrix encapsulation of cancer cells. J Vis Exp (34), pii: 1692, 2009.
133. Simon, K.A., Park, K.M., Mosadegh, B., Subramaniam, A.B., Mazzeo, A.D., Ngo, P.M., and Whitesides, G.M. Polymer-based mesh as supports for multi-layered 3D cell culture and assays. Biomaterials 35, 259, 2014.
134. Mosadegh, B., Lockett, M.R., Minn, K.T., Simon, K.A., Gilbert, K., Hillier, S., Newsome, D., Li, H., Hall, A.B., Boucher, D.M., Eustace, B.K., and Whitesides, G.M. A paper-based invasion assay: assessing chemotaxis of cancer cells in gradients of oxygen. Biomaterials 52, 262, 2015.
135. Xiong, G.Y., Luo, H.L., Zhu, Y., Raman, S., and Wan, Y.Z. Creation of macropores in three-dimensional bacterial cellulose scaffold for potential cancer cell culture. Carbohydr Polym 114, 553, 2014.
136. Innala, M., Riebe, I., Kuzmenko, V., Sundberg, J., Gatenholm, P., Hanse, E., and Johannesson, S. 3D Culturing and differentiation of SH-SY5Y neuroblastoma cells on bacterial nanocellulose scaffolds. Artif Cell Nanomed B 42, 302, 2014.
137. Rodenhizer, D., Gaude, E., Cojocari, D., Mahadevan, R., Frezza, C., Wouters, B.G., and McGuigan, A.P. A threedimensional engineered tumour for spatial snapshot analysis of cell metabolism and phenotype in hypoxic gradients. Nat Mater 15, 227, 2016.
138. Lee, J., Abdeen, A.A., Wycislo, K.L., Fan, T.M., and Kilian, K.A. Interfacial geometry dictates cancer cell tumorigenicity. Nat Mater 2016.
139. Zervantonakis, I.K., Hughes-Alford, S.K., Charest, J.L., Condeelis, J.S., Gertler, F.B., and Kamm, R.D. Threedimensional microfluidic model for tumor cell intravasation and endothelial barrier function. Proc Natl Acad Sci U S A 109, 13515, 2012.
140. Jeon, J.S., Bersini, S., Gilardi, M., Dubini, G., Charest, J.L., Moretti, M., and Kamm, R.D. Human 3D vascularized organotypic microfluidic assays to study breast cancer cell extravasation. Proc Natl Acad Sci U S A 112, 214, 2015.
141. Bruce, A., Evans, R., Mezan, R., Shi, L., Moses, B.S., Martin, K.H., Gibson, L.F., and Yang, Y. Threedimensional microfluidic tri-culture model of the bone marrow microenvironment for study of acute lymphoblastic leukemia. PLoS One 10, e0140506, 2015.
142. Wu, A., Loutherback, K., Lambert, G., Estévez-Salmerón, L., Tlsty, T.D., Austin, R.H., and Sturm, J.C. Cell motility and drug gradients in the emergence of resistance to chemotherapy. Proc Natl Acad Sci U S A 110, 16103, 2013.
143. Tung, Y.C., Hsiao, A.Y., Allen, S.G., Torisawa, Y.S., Ho, M., and Takayama, S. High-Throughput 3D spheroid culture and drug testing using a 384 hanging drop array. Analyst 136, 473, 2011.
144. Luca, A.C., Mersch, S., Deenen, R., Schmidt, S., Messner, I., Schafer, K.L., Baldus, S.E., Huckenbeck, W., Piekorz, R.P., Knoefel, W.T., Krieg, A., and Stoecklein, N.H. Impact of the 3D microenvironment on phenotype, gene expression, and EGFR inhibition of colorectal cancer cell lines. PLoS One 8, e59689, 2013.
145. Swietach, P., Hulikova, A., Patiar, S., Vaughan-Jones, R.D., and Harris, A.L. Importance of intracellular pH in determining the uptake and efficacy of the weakly basic chemotherapeutic drug, doxorubicin. PLoS One 7, e35949, 2012.
146. Lan, S.F., and Starly, B. Alginate based 3D hydrogels as an in vitro co-culture model platform for the toxicity screening of new chemical entities. Toxicol Appl Pharmacol 256, 62, 2011.
147. Zhang, X.X., Wang, W., Yu, W., Xie, Y., Zhang, Y., and Ma, X. Development of an in vitro multicellular tumor spheroid model using microencapsulation and its application in anticancer drug screening and testing. Biotechnol Prog 21, 1289, 2005.
148. Zustiak, S.P., Dadhwal, S., Medina, C., Steczina, S., Chehreghanianzabi, Y., Ashraf, A., and Asuri, P. Threedimensional matrix stiffness and adhesive ligands affect cancer cell response to toxins. Biotechnol Bioeng 113, 443, 2016.
149. Dhiman, H.K., Ray, A.R., and Panda, A.K. Threedimensional chitosan scaffold-based MCF-7 cell culture for the determination of the cytotoxicity of tamoxifen. Biomaterials 26, 979, 2005.
150. Leung, M., Kievit, F.M., Florczyk, S.J., Veiseh, O., Wu, J., Park, J.O., and Zhang, M. Chitosan-Alginate scaffold culture system for hepatocellular carcinoma increases malignancy and drug resistance. Pharm Res 27, 1939, 2010.
151. David, L., Dulong, V., Le Cerf, D., Cazin, L., Lamacz, M., and Vannier, J.P. Hyaluronan hydrogel: an appropriate three-dimensional model for evaluation of anticancer drug sensitivity. Acta Biomater 4, 256, 2008.
152. Gurski, L.A., Jha, A.K., Zhang, C., Jia, X., and Farach-Carson, M.C. Hyaluronic acid-based hydrogels as 3D matrices for in vitro evaluation of chemotherapeutic drugs using poorly adherent prostate cancer cells. Biomaterials 30, 6076, 2009.
153. Kenny, H.A., Lal-Nag, M., White, E.A., Shen, M., Chiang, C.-Y., Mitra, A.K., Zhang, Y., Curtis, M., Schryver, E.M., Bettis, S., Jadhav, A., Boxer, M.B., Li, Z., Ferrer, M., and Lengyel, E. Quantitative high throughput screening using a primary human three-dimensional organotypic culture predicts in vivo efficacy. Nat Commun 6, 6220, 2015.
154. Majumder, B., Baraneedharan, U., Thiyagarajan, S., Radhakrishnan, P., Narasimhan, H., Dhandapani, M., Brijwani, N., Pinto, D.D., Prasath, A., Shanthappa, B.U., Thayakumar, A., Surendran, R., Babu, G.K., Shenoy, A.M., Kuriakose, M.A., Bergthold, G., Horowitz, P., Loda, M., Beroukhim, R., Agarwal, S., Sengupta, S., Sundaram, M., and Majumder, P.K. Predicting clinical response to anticancer drugs using an ex vivo platform that captures tumour heterogeneity. Nat Commun 6, 6169, 2015.
155. Ki, C.S., Shih, H., and Lin, C.C. Effect of 3D matrix compositions on the efficacy of EGFR inhibition in pancreatic ductal adenocarcinoma cells. Biomacromolecules 14, 3017, 2013.
156. Ampuja, M., Jokimaki, R., Juuti-Uusitalo, K., Rodriguez-Martinez, A., Alarmo, E.L., and Kallioniemi, A. BMP4 inhibits the proliferation of breast cancer cells and induces an MMP-dependent migratory phenotype in MDA-MB-231 cells in 3D environment. BMC Cancer 13, 429, 2013.
157. Subia, B., Dey, T., Sharma, S., and Kundu, S.C. Target specific delivery of anticancer drug in silk fibroin based 3D distribution model of bone-breast cancer cells. ACS Appl Mater Interfaces 7, 2269, 2015.
158. Wang, K., Kievit, F.M., Florczyk, S.J., Stephen, Z.R., and Zhang, M. 3D porous chitosan-Alginate scaffolds as an in vitro model for evaluating nanoparticle-mediated tumor targeting and gene delivery to prostate cancer. Biomacromolecules 16, 3362, 2015.
159. Fitzgerald, K.A., Guo, J.F., Tierney, E.G., Curtin, C.M., Malhotra, M., Darcy, R., O Brien, F.J., and O Driscoll, C.M. The use of collagen-based scaffolds to simulate prostate cancer bone metastases with potential for evaluating delivery of nanoparticulate gene therapeutics. Biomaterials 66, 53, 2015.
160. Chandrasekaran, S., Geng, Y., DeLouise, L.A., and King, M.R. Effect of homotypic and heterotypic interaction in 3D on the E-selectin mediated adhesive properties of breast cancer cell lines. Biomaterials 33, 9037, 2012.
161. Sempere, L.F., Gunn, J.R., and Korc, M. A novel 3-dimensional culture system uncovers growth stimulatory actions by TGFb in pancreatic cancer cells. Cancer Biol Ther 12, 198, 2011.
162. Carvalho, M.R., Lima, D., Reis, R.L., Correlo, V.M., and Oliveira, J.M. Evaluating biomaterial-And microfluidicbased 3D tumor models. Trends Biotechnol 33, 667, 2015.
163. Xu, Z., Gao, Y., Hao, Y., Li, E., Wang, Y., Zhang, J., Wang, W., Gao, Z., and Wang, Q. Application of a microfluidic chip-based 3D co-culture to test drug sensitivity for individualized treatment of lung cancer. Biomaterials 34, 4109, 2013.
164. Liu, Z.-B., Zhang, Y., Yu, J.-J., Mak, A.F.-T., Li, Y., and Yang, M. A microfluidic chip with poly(ethylene glycol) hydrogel microarray on nanoporous alumina membrane for cell patterning and drug testing. Sens Actuators B 143, 776, 2010.
165. Sung, J.H., and Shuler, M.L. A micro cell culture analog (microCCA) with 3-D hydrogel culture of multiple cell lines to assess metabolism-dependent cytotoxicity of anticancer drugs. Lab Chip 9, 1385, 2009.